- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
Asthma genetics study finds new gene
By UCSF School of Pharmacy Editorial Staff / Mon Aug 29, 2011
A novel gene associated with the asthma susceptibility in African Americans was revealed by a U.S. consortium of asthma genetics researchers, including Esteban G. Burchard, MD, MPH, Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine. The study also revealed four genes associated with asthma susceptibility that were previously reported in a study of European asthma cases but found to be associated for the first time with asthma risk in three ethnic groups—providing additional evidence that gene variants are significant across ethnicities. The study appeared online July 31, 2011, in Nature Genetics.
Research paper
More
New Asthma Risk Gene Emerges from Study of Diverse Populations
Tags
Category:
Sites:
School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, PharmD Degree Program, QBC, PSPG
Related profiles
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.
